Skip to Main Content

Advertisement

Umbrella Alt Text
header search
Search
Advanced Search
Skip Nav Destination

YC-1 suppresses constitutive nuclear factor-κB activation and induces apoptosis in human prostate cancer cells

Mol Cancer Ther (2005) 4 (10): 1628–1635.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
Recent Progress in Metal‐Catalyzed Selective Oxidation of 5‐Hydroxymethylfurfural into Furan‐Based Value‐Added Chemicals
  • Song Zhang
  • Zhan Chen
  • Jun‐Fei Gu
  • Wei Sang
  • Min Jiang
  • Shuai Li
  • Peng Wang
  • Zongkui Kou
  • Cheng Chen
The Chemical Record (2023) 23 (5)
Revisiting prostate cancer metabolism: From metabolites to disease and therapy
  • Henrique J. Cardoso
  • Tiago M. A. Carvalho
  • Lara R. S. Fonseca
  • Marília I. Figueira
  • Cátia V. Vaz
  • Sílvia Socorro
Medicinal Research Reviews (2021) 41 (3): 1499.
Structure-based strategies for synthesis, lead optimization and biological evaluation of N-substituted anthra[1,2-c][1,2,5]thiadiazole-6,11-dione derivatives as potential multi-target anticancer agents
  • Ahmed Atef Ahmed Ali
  • Yu-Ru Lee
  • Alexander T.H. Wu
  • Vijesh Kumar Yadav
  • Dah-Shyong Yu
  • Hsu-Shan Huang
Arabian Journal of Chemistry (2021) 14 (2): 102884.
YC‑1 reduces inflammatory responses by inhibiting nuclear factor‑κB translocation in mice subjected to transient focal cerebral ischemia
  • Wei‑Ting Lee
  • Shih‑Huang Tai
  • Yu‑Wen Lin
  • Tian‑Shung Wu
  • E‑Jian Lee
Molecular Medicine Reports (2018)
Tumor Hypoxia As an Enhancer of Inflammation-Mediated Metastasis: Emerging Therapeutic Strategies
  • Josh W. DiGiacomo
  • Daniele M. Gilkes
Targeted Oncology (2018) 13 (2): 157.
Pharmacological HIF-inhibition attenuates postoperative adhesion formation
  • Moritz J. Strowitzki
  • Alina S. Ritter
  • Praveen Radhakrishnan
  • Jonathan M. Harnoss
  • Vanessa M. Opitz
  • Marvin Biller
  • Julian Wehrmann
  • Ulrich Keppler
  • Jana Scheer
  • Markus Wallwiener
  • Thomas Schmidt
  • Alexis Ulrich
  • Martin Schneider
Scientific Reports (2017) 7 (1)
YC-1 induces G0/G1phase arrest and mitochondria-dependent apoptosis in cisplatin-resistant human oral cancer CAR cells
  • Miau-Rong Lee
  • Chingju Lin
  • Chi-Cheng Lu
  • Sheng-Chu Kuo
  • Je-Wei Tsao
  • Yu-Ning Juan
  • Hong-Yi Chiu
  • Fang-Yu Lee
  • Jai-Sing Yang
  • Fuu-Jen Tsai
BioMedicine (2017) 7 (2): 12.
Cytotoxic activity of the novel heterocyclic compound G-11 is primarily mediated through intrinsic apoptotic pathway
  • Ayman M. Saleh
  • Mohammad A. Aziz
  • Ibrahim M. Abdou
  • Mutasem O. Taha
  • Mahmoud A. Al-Qudah
  • Mohammed M. Abadleh
  • Ahmad Aljada
  • Syed A. Rizvi
Apoptosis (2016) 21 (7): 873.
Synthesis and biological evaluation of novel 3,9-substituted β-carboline derivatives as anticancer agents
  • Yi-Fong Chen
  • Yi-Chien Lin
  • Jeng-Pang Chen
  • Hsu-Chin Chan
  • Mei-Hua Hsu
  • Hui-Yi Lin
  • Sheng-Chu Kuo
  • Li-Jiau Huang
Bioorganic & Medicinal Chemistry Letters (2015) 25 (18): 3873.
YC-1 enhances the anti-tumor activity of sorafenib through inhibition of signal transducer and activator of transcription 3 (STAT3) in hepatocellular carcinoma
  • Jian Kong
  • Fandong Kong
  • Jun Gao
  • Qiangbo Zhang
  • Shuying Dong
  • Fang Gu
  • Shan Ke
  • Bing Pan
  • Qiang Shen
  • Huichuan Sun
  • Lemin Zheng
  • Wenbing Sun
Molecular Cancer (2014) 13 (1)
Nuclear Factor Kappa-B Signaling Is Integral to Ocular Neovascularization in Ischemia-Independent Microenvironment
  • Michael DeNiro
  • Futwan A. Al-Mohanna
  • Alexander V. Ljubimov
PLoS ONE (2014) 9 (7): e101602.
CLC604 preferentially inhibits the growth of HER2-overexpressing cancer cells and sensitizes these cells to the inhibitory effect of Taxol in vitro and in vivo
  • JANG-CHANG LEE
  • LI-CHEN CHOU
  • JIN-CHEMG LIEN
  • JIA-CHIUN WU
  • CHI-HUNG HUANG
  • CHAO-HO CHUNG
  • FANG-YU LEE
  • LI-JIAU HUANG
  • SHENG-CHU KUO
  • TZONG-DER WAY
Oncology Reports (2013) 30 (4): 1762.
Synthesis and anticancer activity of 2,4-disubstituted furo[3,2-b]indole derivatives
  • Shi-Hong Zhuang
  • Yi-Chien Lin
  • Li-Chen Chou
  • Mei-Hua Hsu
  • Hui-Yi Lin
  • Chi-Hung Huang
  • Jin-Cherng Lien
  • Sheng-Chu Kuo
  • Li-Jiau Huang
European Journal of Medicinal Chemistry (2013) 66: 466.
The Nexus between VEGF and NFκB Orchestrates a Hypoxia-Independent Neovasculogenesis
  • Michael DeNiro
  • Falah H. Al-Mohanna
  • Osama Alsmadi
  • Futwan A. Al-Mohanna
  • Yves St-Pierre
PLoS ONE (2013) 8 (3): e59021.
The anticancer agent YC-1 suppresses progestin-stimulated VEGF in breast cancer cells and arrests breast tumor development
  • CANDACE E. CARROLL
  • YAYUN LIANG
  • INDIRA BENAKANAKERE
  • CYNTHIA BESCH-WILLIFORD
  • SALMAN M. HYDER
International Journal of Oncology (2013) 42 (1): 179.
Inhibition of NF-κB by Opioids in T Cells
  • Christine Börner
  • Jürgen Kraus
The Journal of Immunology (2013) 191 (9): 4640.
The ubiquitin-proteasome system in prostate cancer and its transition to castration resistance
  • Ioannis A. Voutsadakis
  • Christos N. Papandreou
Urologic Oncology: Seminars and Original Investigations (2012) 30 (6): 752.
Bp5250 inhibits vascular endothelial growth factor-induced angiogenesis and HIF-1α expression on endothelial cells
  • Kuan-Ting Lin
  • Jin-Cherng Lien
  • Ching-Hu Chung
  • Sheng-Chu Kuo
  • Tur-Fu Huang
Naunyn-Schmiedeberg's Archives of Pharmacology (2012) 385 (1): 39.
YC-1, a novel potential anticancer agent, inhibit multidrug-resistant protein via cGMP-dependent pathway
  • Chin-Chuan Hung
  • Horng-Huei Liou
Investigational New Drugs (2011) 29 (6): 1337.
YC‐1 rescues cancer cachexia by affecting lipolysis and adipogenesis
  • Tsai‐Hua Chung
  • Mark Yen‐Ping Kuo
  • Jen‐Kun Chen
  • Dong‐Ming Huang
International Journal of Cancer (2011) 129 (9): 2274.
Cyclic GMP induced apoptosis via protein kinase G in oestrogen receptor‐positive and ‐negative breast cancer cell lines
  • Faranak Fallahian
  • Fatemeh Karami‐Tehrani
  • Siamak Salami
  • Mahmoud Aghaei
The FEBS Journal (2011) 278 (18): 3360.
Kmup-1 Inhibits H441 Lung Epithelial Cell Growth, Migration and Proinflammation VIA Increased NO/CGMP and Inhibited RHO KINASE/VEGF Signaling Pathways
  • B.N. Wu
  • H.Y. Chen
  • C.P. Liu
  • L.Y. Hsu
  • I.J. Chen
International Journal of Immunopathology and Pharmacology (2011) 24 (4): 925.
Effects of TLR Agonists on the Hypoxia-Regulated Transcription Factor HIF-1α and Dendritic Cell Maturation under Normoxic Conditions
  • Rolf Spirig
  • Siamak Djafarzadeh
  • Tomas Regueira
  • Sidney G. Shaw
  • Christophe von Garnier
  • Jukka Takala
  • Stephan M. Jakob
  • Robert Rieben
  • Philipp M. Lepper
  • Patricia T. Bozza
PLoS ONE (2010) 5 (6): e10983.
Reverse phase protein array identifies novel anti-invasion mechanisms of YC-1
  • Bo Hong
  • Vivian W.Y. Lui
  • Edwin P. Hui
  • Yiling Lu
  • Horasis S.Y. Leung
  • Elaine Y.L. Wong
  • Suk-Hang Cheng
  • Margaret H.L. Ng
  • Gordon B. Mills
  • Anthony T.C. Chan
Biochemical Pharmacology (2010) 79 (6): 842.
YC-1 enhances natural killer cell differentiation from hematopoietic stem cells
  • Sohyun Yun
  • Suk Hyung Lee
  • Yun Hee Kang
  • Mira Jeong
  • Mi Jeong Kim
  • Mi Sun Kim
  • Zheng-Hao Piao
  • Hyun-Woo Suh
  • Tae-don Kim
  • Pyung-Keun Myung
  • Suk-Ran Yoon
  • Inpyo Choi
International Immunopharmacology (2010) 10 (4): 481.
A mass spectrometric investigation of the ability of metal complexes to modulate transcription factor activity
  • Jihan Talib
  • Jennifer L. Beck
  • Thitima Urathamakul
  • Cuong D. Nguyen
  • Janice R. Aldrich-Wright
  • Joel P. Mackay
  • Stephen F. Ralph
Chemical Communications (2009) (37): 5546.
Inhibition of constitutive and cxc-chemokine-induced NF-κB activity potentiates ansamycin-based HSP90-inhibitor cytotoxicity in castrate-resistant prostate cancer cells
  • A Seaton
  • P J Maxwell
  • A Hill
  • R Gallagher
  • J Pettigrew
  • R H Wilson
  • D J J Waugh
British Journal of Cancer (2009) 101 (9): 1620.
Decrease in RelA phosphorylation by inhibiting protein kinase A induces cell death in NF-κB-expressing and drug-resistant tumor cells
  • Sunil K. Manna
  • Charitha Gangadharan
Molecular Immunology (2009) 46 (7): 1340.
Modulating the hypoxia-inducible factor signaling pathway as a therapeutic modality to regulate retinal angiogenesis
  • M. DeNiro
  • O. Alsmadi
  • F. Al-Mohanna
Experimental Eye Research (2009) 89 (5): 700.
Regulation of HIV-1 transcription in cells of the monocyte-macrophage lineage
  • Evelyn M Kilareski
  • Sonia Shah
  • Michael R Nonnemacher
  • Brian Wigdahl
Retrovirology (2009) 6 (1)
YC‐1 induces apoptosis of human renal carcinoma A498 cells in vitro and in vivo through activation of the JNK pathway
  • S Y Wu
  • S L Pan
  • T H Chen
  • C H Liao
  • D Y Huang
  • J H Guh
  • Y L Chang
  • S C Kuo
  • F Y Lee
  • C M Teng
British Journal of Pharmacology (2008) 155 (4): 505.
Chemotherapy-Induced CXC-Chemokine/CXC-Chemokine Receptor Signaling in Metastatic Prostate Cancer Cells Confers Resistance to Oxaliplatin through Potentiation of Nuclear Factor-κB Transcription and Evasion of Apoptosis
  • Catherine Wilson
  • Colin Purcell
  • Angela Seaton
  • Olabode Oladipo
  • Pamela J. Maxwell
  • Joe M. O'Sullivan
  • Richard H. Wilson
  • Patrick G. Johnston
  • David J. J. Waugh
Journal of Pharmacology and Experimental Therapeutics (2008) 327 (3): 746.
Anticancer mechanisms of YC-1 in human lung cancer cell line, NCI-H226
  • Chun-Jen Chen
  • Mei-Hua Hsu
  • Li-Jiau Huang
  • Takao Yamori
  • Jing-Gung Chung
  • Fang-Yu Lee
  • Che-Ming Teng
  • Sheng-Chu Kuo
Biochemical Pharmacology (2008) 75 (2): 360.
YC-1 INDUCES HEAT SHOCK PROTEIN 70 EXPRESSION AND PREVENTS OXIDIZED LDL-MEDIATED APOPTOSIS IN VASCULAR SMOOTH MUSCLE CELLS
  • Yi-Nan Liu
  • Shiow-Lin Pan
  • Chieh-Yu Peng
  • Der-Yi Huang
  • Jih-Hwa Guh
  • Sheng-Chu Kuo
  • Fang-Yu Lee
  • Che-Ming Teng
Shock (2008) 30 (3): 274.
Synthesis of furopyrazole analogs of 1-benzyl-3-(5-hydroxymethyl-2-furyl)indazole (YC-1) as novel anti-leukemia agents
  • Li-Chen Chou
  • Li-Jiau Huang
  • Jai-Sing Yang
  • Fang-Yu Lee
  • Che-Ming Teng
  • Sheng-Chu Kuo
Bioorganic & Medicinal Chemistry (2007) 15 (4): 1732.
Proteomic approach to studying the cytotoxicity of YC‐1 on U937 leukemia cells and antileukemia activity in orthotopic model of leukemia mice
  • Jing‐Gung Chung
  • Jai‐Sing Yang
  • Li‐Jiau Huang
  • Fang‐Yu Lee
  • Che‐Ming Teng
  • Sheng‐Chung Tsai
  • Kuei‐Li Lin
  • Shu‐Fang Wang
  • Sheng‐Chu Kuo
PROTEOMICS (2007) 7 (18): 3305.
YC-1 inhibits HIF-1 expression in prostate cancer cells: contribution of Akt/NF-κB signaling to HIF-1α accumulation during hypoxia
  • H-L Sun
  • Y-N Liu
  • Y-T Huang
  • S-L Pan
  • D-Y Huang
  • J-H Guh
  • F-Y Lee
  • S-C Kuo
  • C-M Teng
Oncogene (2007) 26 (27): 3941.
YC‐1 attenuates LPS‐induced proinflammatory responses and activation of nuclear factor‐κB in microglia
  • D‐Y Lu
  • C‐H Tang
  • H‐C Liou
  • C‐M Teng
  • K‐Cg Jeng
  • S‐C Kuo
  • F‐Y Lee
  • W‐M Fu
British Journal of Pharmacology (2007) 151 (3): 396.
Mechanisms of antiprostate cancer by gum mastic: NF-?B signal as target
  • Mei-lan HE
  • Ang LI
  • Chun-su XU
  • Shun-li WANG
  • Meng-jie ZHANG
  • Hua GU
  • Yao-qin YANG
  • Hui-hong TAO
Acta Pharmacologica Sinica (2007) 28 (3): 446.
Suppression of hypoxia inducible factor-1α (HIF-1α) by YC-1 is dependent on murine double minute 2 (Mdm2)
  • Chi Keung Lau
  • Zhen Fan Yang
  • Chi Tat Lam
  • Ka Ho Tam
  • Ronnie Tung Ping Poon
  • Sheung Tat Fan
Biochemical and Biophysical Research Communications (2006) 348 (4): 1443.
Targeting transcription factors in cancer: Challenges and evolving strategies
  • Michele S. Redell
  • David J. Tweardy
Drug Discovery Today: Technologies (2006) 3 (3): 261.
  • Online ISSN 1538-8514
  • Print ISSN 1535-7163

AACR Journals

 

 

  • Copyright © 2023 by the American Association for Cancer Research.
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.
Accept